ciprofloxacin has been researched along with acyclovir in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (9.09) | 18.2507 |
| 2000's | 7 (21.21) | 29.6817 |
| 2010's | 20 (60.61) | 24.3611 |
| 2020's | 3 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Jolivette, LJ; Ward, KW | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Avdeef, A; Sun, N; Tam, KY; Tsinman, O | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Avdeef, A; Tam, KY | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Augustynowicz-Kopeć, E; Bielenica, A; Boi, S; Giliberti, G; Madeddu, S; Napiórkowska, A; Sanna, G; Stefańska, J; Stępień, K; Struga, M; Wrzosek, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Ohno, I | 1 |
| Brunet, J; Cancelas, JA; López-López, JJ; Maroto, P; Mendoza, L; Montesinos, J; Ojeda, B; Rodríguez, M; Salazar, R; Solá, C; Tabernero, JM; Valentí, V; Verger, G | 1 |
| Andresen, S; Bolwell, B; Goormastic, M; Kalaycio, M; Pohlman, B; Wise, K | 1 |
| Halgren, JT; Pandit, RT; Sutphin, JE; Wagoner, MD | 1 |
| Bonferoni, MC; Caramella, C; Ferrari, F; Gibin, S; Rossi, S; Sandri, G | 1 |
| Huh, J; Kang, EH; Kim, S; Kim, SH; Lee, DH; Lee, K; Park, JS; Sohn, BS; Suh, C; Yoon, DH | 1 |
| Adil, SN; Ali, N; Shaikh, MU | 1 |
| Awwad, S; Baskakova, A; Brocchini, S; Gill, H; Jiménez, JQ; Khaw, PT; Novikov, O; Williams, GR; Zhilyakova, E | 1 |
| Bergami, E; Cavanna, C; Decembrino, N; Introzzi, F; Lallitto, F; Mangione, F; Marone, P; Tamarozzi, F; Tortorano, AM; Zecca, M | 1 |
| Kanfer, I; Patnala, S; Reddy, NH | 1 |
| Rabadi, MH | 1 |
| Beaussac, M; Coton, T; Deniel, C; Javelle, E; Luciano, L; Savini, H; Simon, F | 1 |
| Campos Mollo, E; Matarredona Muñoz, J; Moya Roca, J; Porcar Plana, CA | 1 |
| Fang, Y; Li, Y; Zhang, T; Zou, P | 1 |
3 review(s) available for ciprofloxacin and acyclovir
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Ciprofloxacin nephropathy, acyclovir nephropathy].
Topics: Acyclovir; Anti-Infective Agents; Antiviral Agents; Ciprofloxacin; Humans; Kidney Diseases | 1997 |
30 other study(ies) available for ciprofloxacin and acyclovir
| Article | Year |
|---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
Topics: Caco-2 Cells; Cell Membrane Permeability; Humans; Hydrogen-Ion Concentration; Membranes, Artificial; Molecular Structure; Pharmaceutical Preparations | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis, cytotoxicity and antimicrobial activity of thiourea derivatives incorporating 3-(trifluoromethyl)phenyl moiety.
Topics: Aniline Compounds; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cell Line; Cell Proliferation; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Fungi; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiourea; Topoisomerase Inhibitors | 2015 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Topics: Acyclovir; Adolescent; Adult; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Ciprofloxacin; Combined Modality Therapy; Communicable Diseases; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Itraconazole; Male; Middle Aged; Neoplasms; Prospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Transplantation, Autologous; Treatment Outcome | 1999 |
LDH elevation after autologous stem cell transplantation.
Topics: Acyclovir; Antigens, CD34; Antineoplastic Agents, Alkylating; Blood Component Removal; Ciprofloxacin; Cyclophosphamide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; L-Lactate Dehydrogenase; Middle Aged; Retrospective Studies; Stem Cells; Thiotepa; Transplantation, Autologous | 1999 |
Triple anterior stromal ring infiltrate associated with presumed HSV keratitis.
Topics: Acyclovir; Anti-Infective Agents; Antiviral Agents; Ciprofloxacin; Corneal Stroma; Drug Therapy, Combination; Glucocorticoids; Herpesvirus 1, Human; Humans; Keratitis, Herpetic; Male; Middle Aged; Ofloxacin; Prednisolone | 2001 |
Chitosan citrate as multifunctional polymer for vaginal delivery. Evaluation of penetration enhancement and peptidase inhibition properties.
Topics: Acyclovir; Adjuvants, Pharmaceutic; Administration, Intravaginal; Animals; Biological Availability; Caco-2 Cells; Carboxypeptidases A; Cell Survival; Chitosan; Ciprofloxacin; Dextrans; Fluorescein-5-isothiocyanate; Humans; Intestinal Absorption; Leucyl Aminopeptidase; Mucous Membrane; Protease Inhibitors; Sus scrofa; Vaginal Creams, Foams, and Jellies; Viscosity | 2008 |
The role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experience.
Topics: Acyclovir; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Antiviral Agents; Chemoprevention; Ciprofloxacin; Escherichia coli; Female; Fever of Unknown Origin; Fluconazole; Humans; Immunocompromised Host; Incidence; Male; Middle Aged; Staphylococcus aureus; Stem Cell Transplantation; Treatment Outcome; Young Adult | 2012 |
Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
Topics: Acyclovir; Adolescent; Adult; Anti-Infective Agents; Bacteremia; Candida albicans; Candidiasis; Catheterization, Central Venous; Catheters, Indwelling; Child; Child, Preschool; Ciprofloxacin; Developing Countries; Escherichia coli; Escherichia coli Infections; Febrile Neutropenia; Female; Fluconazole; Fungemia; Fusariosis; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pakistan; Retrospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Valacyclovir; Valine; Virus Diseases; Young Adult | 2014 |
Electrospun formulations of acyclovir, ciprofloxacin and cyanocobalamin for ocular drug delivery.
Topics: Acyclovir; Administration, Ophthalmic; Anti-Bacterial Agents; Antiviral Agents; Ciprofloxacin; Drug Compounding; Drug Delivery Systems; Drug Liberation; Eye; Polyesters; Povidone; Vitamin B 12; Vitamin B Complex | 2016 |
Acute isolated appendicitis due to Aspergillus carneus in a neutropenic child with acute myeloid leukemia.
Topics: Acute Disease; Acyclovir; Amphotericin B; Antifungal Agents; Appendicitis; Aspergillosis; Aspergillus; Child; Ciprofloxacin; Fluconazole; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Voriconazole | 2016 |
Investigation of Biowaivers for Immediate Release Formulations Containing BCS III Drugs, Acyclovir, Atenolol, and Ciprofloxacin Hydrochloride, Using Dissolution Testing.
Topics: Acyclovir; Atenolol; Biopharmaceutics; Chemistry, Pharmaceutical; Ciprofloxacin; Dosage Forms; India; Solubility; South Africa; Therapeutic Equivalency | 2017 |
Brought Down by a Mosquito? West Nile Virus Encephalitis.
Topics: Acyclovir; Anti-Infective Agents; Brain; Ceftriaxone; Ciprofloxacin; Consciousness Disorders; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paresis; Vancomycin; West Nile Fever; West Nile virus | 2018 |
Primary Infectious Acute Pancreatitis: A 9 Case Series.
Topics: Acute Disease; Acyclovir; Adult; Anti-Bacterial Agents; Antiviral Agents; Bacterial Infections; Cephalosporins; Ciprofloxacin; Female; Humans; Male; Pancreatitis; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Virus Diseases | 2020 |
Moraxella nonliquefaciens superinfecting herpes simplex keratitis.
Topics: Acyclovir; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Cyclopentolate; Female; Humans; Keratitis, Herpetic; Moraxella; Prednisolone; Vancomycin | 2022 |
Physiologically based pharmacokinetic model to predict drug concentrations of breast cancer resistance protein substrates in milk.
Topics: Acyclovir; ATP Binding Cassette Transporter, Subfamily G, Member 2; Bupropion; Cimetidine; Ciprofloxacin; Female; Humans; Infant; Lactation; Milk, Human; Models, Biological; Neoplasm Proteins; Nitrofurantoin | 2022 |